An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital

Seizure

Volumn 14, Issue 6, 2005, Pages 422-428

  Chappell, Brian ^a   Crawford, Pamela ^a  

^a YORK HOSPITAL   (United Kingdom)

Author keywords

Anti epileptic drugs; Audit; Outpatients; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; LAMOTRIGINE; NEW DRUG; TOPIRAMATE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; DRUG CHOICE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; EPILEPSY; FEMALE; GENERAL HOSPITAL; GENERALIZED EPILEPSY; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HOSPITAL; SYMPTOMATIC EPILEPSY; TREATMENT OUTCOME;

ADULT; AGED; ANTICONVULSANTS; COHORT STUDIES; DRUG UTILIZATION; EPILEPSY; EPILEPSY, GENERALIZED; FEMALE; FRUCTOSE; GREAT BRITAIN; HOSPITALS, GENERAL; HUMANS; KNOWLEDGE BASES; LEARNING DISORDERS; MALE; MEDICAL AUDIT; MIDDLE AGED; PATIENT DROPOUTS; PIRACETAM; TRIAZINES;

EID: 23944454573     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.07.005     Document Type: Article

References (31)

1. M.J. Brodie A. Richens A.W. Yuen Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/ Carbamazepine Monotherapy Trial Group Lancet 345 8948 1995 476-479
2. M. Dam R. Ekberg Y. Loyning O. Waltimo K. Jakobsen A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed previously untreated epilepsy Epilepsy Res 3 1989 70-76
3. M. Guerreiro U. Vigonius H. Pohlmann M.L. de Manreza N. Fejeman S.A. Antoniuk et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy Epilepsy Res 27 1997 195-204
4. IMS Health Limited, Medical Data Index. London; July-September 2004.
5. T. Betts T. Waegemans P. Crawford A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy Seizure 9 2 2000 80-87
6. S.D. Shorvon A. Lowenthal D. Janz E. Bielen P. Loiseau Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group Epilepsia 41 9 2000 1179-1186
7. F. Matsuo D. Bergen E. Faught J.A. Messenheimer A.T. Dren G.D. Rudd C.G. Lineberry Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0. 5 Clinical Trial Group Neurology 43 11 1993 2284-2291
8. J. Messenheimer R.E. Ramsay L.J. Willmore R.F. Leroy J.J. Zielinski et al. Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, cross-over trial Epilepsia 35 1 1994 113-121
9. R.A. Reife G.W. Pledger Topiramate as adjunctive therapy in refractory partial epilepsy: Pooled analysis of data from five double-blind, placebo-controlled trials Epilepsia 38 Suppl. 1 1997 S31-S33
10. E. Ben-Menachem Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: The European experience Epilepsia 38 Suppl. 1 1997 S28-S30
11. F.M. Besag S.J. Wallace O. Dulac J. Alving S.C. Spencer G. Hosking Lamotrigine for the treatment of epilepsy in childhood J Pediatr 127 6 1995 991-997
12. A.S. Eriksson A. Nergardh K. Hoppu The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: A randomized, double-blind, crossover study Epilepsia 39 5 1998 495-501
13. Y. Mikaeloff A. de Saint-Martin J. Mancini S. Peudenier J.M. Pedespan et al. Topiramate: Efficacy and tolerability in children according to epilepsy syndromes Epilepsy Res 53 3 2003 225-232
14. V. Biton G.D. Montouris F. Ritter J.J. Riviello R. Reife et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group Neurology 52 7 1999 1330-1337
15. E. Ben-Menachem E. Gilland Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy Seizure 12 3 2003 131-135
16. T. Betts H. Yarrow L. Greenhill M. Barrett Clinical experience of marketed Levetiracetam in an epilepsy clinic-a one year follow up study Seizure 12 3 2003 136-140
17. P. Crawford S. Brown M. Kerr Parke Davis Clinical Trials Group A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy Seizure 10 2 2001 107-115
18. K. Kelly L.J. Stephen G.J. Sills M.J. Brodie Topiramate in patients with learning disability and refractory epilepsy Epilepsia 43 4 2002 399-402
19. L.J. Stephen G.J. Sills M.J. Brodie Topiramate in refractory epilepsy: A prospective observational study Epilepsia 41 8 2000 977-980
20. S. Kaiser C.E. Selai M.R. Trimble Long-term follow-up of topiramate and lamotrigine: A perspective on quality of life Seizure 11 6 2002 356-360
21. P.K. Datta P.M. Crawford Refractory epilepsy: Treatment with new antiepileptic drugs Seizure 9 1 2000 51-57
22. S.D. Lhatoo I.C. Wong G. Polizzi J.W. Sander Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy Epilepsia 41 12 2000 1592-1596
23. K. Mohamed R. Appleton L. Rosenbloom Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: A clinical experience Seizure 9 2 2000 137-141
24. M.W. Kellett D.F. Smith P.A. Stockton D.W. Chadwick Topiramate in clinical practice: First year's postlicensing experience in a specialist epilepsy clinic J Neurol Neurosurg Psychiatry 66 6 1999 759-763
25. R. Gillham K. Kane L. Bryant-Comstock M.J. Brodie A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure Seizure 9 6 2000 375-379
26. P.J. Martin P.A. Millac Impact of lamotrigine on patients with refractory epilepsy: The Leicester experience Seizure 3 3 1994 209-213
27. M. Alegre J. Iriarte E. Schlumberger E. Urrestarazu D. Lazaro C. Viteri Lamotrigine in the adult-onset epilepsy: Efficacy and long-term safety Neurologia 17 3 2002 136-142
28. T.L. Collins O.A. Petroff R.H. Mattson A comparison of four new antiepileptic medications Seizure 9 4 2000 291-293
29. P.D. Knoester S.V. Belitser C.L. Deckers A. Keyser W.O. Renier Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the Netherlands J Clin Pharm Ther 29 2 2004 131-138
30. J.A. Cramer E. Ben Menachem J. French Review of treatment options for refractory epilepsy: New medications and vagal nerve stimulation Epilepsy Res 47 1-2 2001 17-25
31. J.M. Bird Z.A. Joseph Levetiracetam in clinical use - A prospective observational study Seizure 12 8 2003 613-616